BALYASNY ASSET MANAGEMENT L.P. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$418
-99.9%
11
-100.0%
0.00%
-100.0%
Q3 2022$767,000
-73.9%
30,518
-68.4%
0.00%
-80.0%
Q2 2022$2,935,000
+881.6%
96,598
+959.5%
0.01%
+900.0%
Q1 2022$299,000
-92.2%
9,117
-93.7%
0.00%
-92.3%
Q4 2021$3,811,000
-82.7%
144,521
-34.6%
0.01%
-88.0%
Q1 2021$22,044,000
+200.6%
221,109
+193.7%
0.11%
+100.0%
Q3 2020$7,334,000
+265.8%
75,284
+441.8%
0.05%
+125.0%
Q1 2020$2,005,00013,8950.02%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders